| 前收市價 | 229.70 |
| 開市 | 229.70 |
| 買盤 | 233.00 x 1200 |
| 賣出價 | 242.70 x 1200 |
| 今日波幅 | 229.70 - 229.70 |
| 52 週波幅 | 226.00 - 336.30 |
| 成交量 | |
| 平均成交量 | 2,082 |
| 市值 | 14.99B |
| Beta 值 (5 年，每月) | 0.86 |
| 市盈率 (最近 12 個月) | 18.72 |
| 每股盈利 (最近 12 個月) | 12.42 |
| 業績公佈日 | 2024年11月06日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 無 |
Insider MonkeyGenmab A/S (GMAB): Among The Stocks With Biggest Upside Potential According to Hedge Funds
We recently compiled a list of the 10 Stocks with Biggest Upside Potential According to Hedge Funds. In this article, we are going to take a look at where Genmab A/S (NASDAQ:GMAB) stands against the other stocks with biggest upside potential. The US equities saw a strong move after the September jobs report exceeded the economists’ estimates. As […]
ZacksGMAB or INCY: Which Is the Better Value Stock Right Now?
GMAB vs. INCY: Which Stock Is the Better Value Option?
ZacksDown -14.68% in 4 Weeks, Here's Why Genmab (GMAB) Looks Ripe for a Turnaround
Genmab (GMAB) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
